Other conditions showing signals Emerging research suggests potential benefit in gout (reduced risk of development in GLP-1 users), osteoarthritis (improved joint outcomes in semaglutide users), and endometriosis (anti-inflammatory mechanisms relevant to endometrial inflammation)
In most cases, patients with a BMI below 27 do not qualify for GLP-1 medications prescribed specifically for weight management
Patients should never skip this titration process or increase doses more rapidly than recommended, as this significantly increases the risk and severity of gastrointestinal side effects
Great company
Introduction If you take semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), you may wonder how long the medication stays in your body after a dose
Men, however, did not see an increase in acne